71 related articles for article (PubMed ID: 8933284)
1. IA-2 and IA-2 beta are major autoantigens in IDDM and the precursors of the 40 kDa and 37 kDa tryptic fragments.
Notkins AL; Lu J; Li Q; VanderVegt FP; Wasserfall C; Maclaren NK; Lan MS
J Autoimmun; 1996 Oct; 9(5):677-82. PubMed ID: 8933284
[TBL] [Abstract][Full Text] [Related]
2. Autoantigens in insulin-dependent diabetes mellitus: molecular cloning and characterization of human IA-2 beta.
Li Q; Borovitskaya AE; DeSilva MG; Wasserfall C; Maclaren NK; Notkins AL; Lan MS
Proc Assoc Am Physicians; 1997 Jul; 109(4):429-39. PubMed ID: 9220540
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to IA-2 and IA-2 beta in insulin-dependent diabetes mellitus recognize conformational epitopes: location of the 37- and 40-kDa fragments determined.
Xie H; Zhang B; Matsumoto Y; Li Q; Notkins AL; Lan MS
J Immunol; 1997 Oct; 159(7):3662-7. PubMed ID: 9317167
[TBL] [Abstract][Full Text] [Related]
4. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.
Bonifacio E; Lampasona V; Genovese S; Ferrari M; Bosi E
J Immunol; 1995 Dec; 155(11):5419-26. PubMed ID: 7594559
[TBL] [Abstract][Full Text] [Related]
5. Comparison of IA-2 with IA-2beta and with six other members of the protein tyrosine phosphatase family: recognition of antigenic determinants by IDDM sera.
Notkins AL; Zhang B; Matsumoto Y; Lan MS
J Autoimmun; 1997 Jun; 10(3):245-50. PubMed ID: 9218750
[TBL] [Abstract][Full Text] [Related]
6. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
Bonifacio E; Lampasona V; Bingley PJ
J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
[TBL] [Abstract][Full Text] [Related]
7. Detection of proteolytic cleavages of diabetes-associated protein IA-2 beta in the pancreas and the brain using novel anti-IA-2 beta monoclonal antibodies.
Kawakami T; Saeki K; Takeyama N; Wu G; Sakudo A; Matsumoto Y; Hayashi T; Onodera T
Int J Mol Med; 2007 Aug; 20(2):177-85. PubMed ID: 17611635
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen.
Lampasona V; Bearzatto M; Genovese S; Bosi E; Ferrari M; Bonifacio E
J Immunol; 1996 Sep; 157(6):2707-11. PubMed ID: 8805677
[TBL] [Abstract][Full Text] [Related]
9. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus.
Lan MS; Wasserfall C; Maclaren NK; Notkins AL
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6367-70. PubMed ID: 8692821
[TBL] [Abstract][Full Text] [Related]
10. Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512).
Payton MA; Hawkes CJ; Christie MR
J Clin Invest; 1995 Sep; 96(3):1506-11. PubMed ID: 7657822
[TBL] [Abstract][Full Text] [Related]
11. Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment.
Lu J; Li Q; Xie H; Chen ZJ; Borovitskaya AE; Maclaren NK; Notkins AL; Lan MS
Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2307-11. PubMed ID: 8637868
[TBL] [Abstract][Full Text] [Related]
12. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
[TBL] [Abstract][Full Text] [Related]
13. The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2.
Passini N; Larigan JD; Genovese S; Appella E; Sinigaglia F; Rogge L
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9412-6. PubMed ID: 7568143
[TBL] [Abstract][Full Text] [Related]
14. ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies.
Miao D; Yu L; Tiberti C; Cuthbertson DD; Rewers M; di Mario U; Eisenbarth GS; Dotta F
J Autoimmun; 2002 Mar; 18(2):191-6. PubMed ID: 11908951
[TBL] [Abstract][Full Text] [Related]
15. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
[TBL] [Abstract][Full Text] [Related]
16. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
[TBL] [Abstract][Full Text] [Related]
17. Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2.
Hawkes CJ; Wasmeier C; Christie MR; Hutton JC
Diabetes; 1996 Sep; 45(9):1187-92. PubMed ID: 8772720
[TBL] [Abstract][Full Text] [Related]
18. Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65.
Chen S; Willis J; Maclean C; Ananieva-Jordanova R; Amoroso MA; Brooking H; Powell M; Collins A; Bennett S; Mitchell S; Burne P; Furmaniak J; Smith BR
Clin Chim Acta; 2005 Jul; 357(1):74-83. PubMed ID: 15963796
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus.
Davison LJ; Weenink SM; Christie MR; Herrtage ME; Catchpole B
Vet Immunol Immunopathol; 2008 Nov; 126(1-2):83-90. PubMed ID: 18706702
[TBL] [Abstract][Full Text] [Related]
20. Two distinctly HLA-associated contiguous linear epitopes uniquely expressed within the islet antigen 2 molecule are major autoantibody epitopes of the diabetes-specific tyrosine phosphatase-like protein autoantigens.
Bearzatto M; Naserke H; Piquer S; Koczwara K; Lampasona V; Williams A; Christie MR; Bingley PJ; Ziegler AG; Bonifacio E
J Immunol; 2002 Apr; 168(8):4202-8. PubMed ID: 11937581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
